Fully Automatic Assessment of Bronchus-Artery Dimensions and Ratios, Mucus Plugs, and Low Attenuation Regions in Cystic Fibrosis Patients Before and After Elexacaftor-Tezacaftor-IvacaftorLeyla Suleymanova2024-05-29T11:18:43+00:00
The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6–11 with cystic fibrosis in a real-world settingLeyla Suleymanova2023-10-23T11:24:52+00:00
Automatic Bronchus and Artery Analysis on Chest Computed Tomography to Evaluate the Effect of Inhaled Hypertonic Saline in Children Aged 3-6 Years With Cystic Fibrosis in a Randomized Clinical TrialLeyla Suleymanova2023-10-23T11:24:56+00:00